The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Stimulating the GPR30 Estrogen Receptor with a Novel Tamoxifen Analogue Activates SF-1 and Promotes Endometrial Cell Proliferation
Open accessPublished version of a preprint
Abstract
Estrogens and selective estrogen receptor (ER) modulators such as tamoxifen are known to increase uterine cell proliferation. Mounting evidence suggests that estrogen signaling is mediated not only by ERα and ERβ nuclear receptors, but also by GPR30 (GPER), a seven transmembrane (7TM) receptor. Here, we report that primary human endometriotic H-38 cells express high levels of GPR30 with no detectable ERα or ERβ. Using a novel tamoxifen analogue, STX, which activates GPR30 but not ERs, significant stimulation of the phosphatidylinositol 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) pathways was observed in H-38 cells and in Ishikawa endometrial cancer cells expressing GPR30; a similar effect was observed in JEG3 choriocarcinoma cells. STX treatment also increased cellular pools of phosphatidylinositol (3,4,5) triphosphate, a proposed ligand for the nuclear hormone receptor SF-1 (NR5A1). Consistent with these findings, STX, tamoxifen, and the phytoestrogen genistein were able to increase SF-1 transcription, promote Ishikawa cell proliferation, and induce the SF-1 target gene aromatase in a GPR30-dependent manner. Our findings suggest a novel signaling paradigm that is initiated by estrogen activation of the 7TM receptor GPR30, with signal transduction cascades (PI3K and MAPK) converging on nuclear hormone receptors (SF-1/LRH-1) to modulate their transcriptional output. We propose that this novel GPR30/SF-1 pathway increases local concentrations of estrogen, and together with classic ER signaling, mediate the proliferative effects of synthetic estrogens such as tamoxifen, in promoting endometriosis and endometrial cancers. [Cancer Res 2009;69(13):5415–23]
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Vivacqua, A., Bonofiglio, D., Albanito, L., Madeo, A., Rago, V., Carpino, A., Musti, A. M., Picard, D., Andò, S., & Maggiolini, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026344 · Cited by 280
RetractedA transmembrane intracellular estrogen receptor mediates rapid cell signaling
Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005) · Science · doi:10.1126/science.1106943 · Cited by 2,302
A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer
The Breast International Group (BIG) 1-98 Collaborative Group (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052258 · Cited by 1,584
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
Simoncini, T., Hafezi‐Moghadam, A., Brazil, D. P., Ley, K. F., Chin, W. W., & Liao, J. K. (2000) · Nature · doi:10.1038/35035131 · Cited by 1,436
Identity of an Estrogen Membrane Receptor Coupled to a G Protein in Human Breast Cancer Cells
Thomas, P., Pang, Y., Filardo, E. J., & Dong, J. (2004) · Endocrinology · doi:10.1210/en.2004-1064 · Cited by 1,410
Filardo, E. J., Quinn, J. A., Bland, K. I., & Frackelton, A. R. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.10.0532 · Cited by 1,387
Filardo, E. J., Quinn, J. A., Frackelton, A. R., & Bland, K. I. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.1.0758 · Cited by 907
Virtual and biomolecular screening converge on a selective agonist for GPR30
Bologa, C., Revankar, C. M., Young, S. M., Edwards, B. S., Arterburn, J. B., Kiselyov, A. S., Parker, M. A., Tkachenko, S. E., Savchuk, N., Sklar, L. A., et al. (2006) · Nature Chemical Biology · doi:10.1038/nchembio775 · Cited by 819
Burney, R. O., Talbi, S., Hamilton, A. E., Vo, K. C., Nyegaard, M., Nezhat, C. R., Lessey, B. A., & Giudice, L. C. (2007) · Endocrinology · doi:10.1210/en.2006-1692 · Cited by 735
Integration of the extranuclear and nuclear actions of estrogen
Levin, E. R. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0390 · Cited by 708
Cited by
Sorted by citations
The G-protein-coupled estrogen receptor GPER in health and disease
Prossnitz, E. R., & Barton, M. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.122 · Cited by 925
“In turn, these signaling pathways also activate other transcription factors, such as steroidogenic factor 1”
BackgroundEstrogen biology: New insights into GPER function and clinical opportunities
Prossnitz, E. R., & Barton, M. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.02.002 · Cited by 404
The unfolding stories of GPR30, a new membrane-bound estrogen receptor
Maggiolini, M., & Picard, D. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0242 · Cited by 360
Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors
Meyer, M. R., Clegg, D. J., Prossnitz, E. R., & Barton, M. (2011) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02237.x · Cited by 338
Minireview: steroidogenic factor 1: its roles in differentiation, development, and disease
Schimmer, B. P., & White, P. C. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0519 · Cited by 268
Prossnitz, E. R., & Arterburn, J. B. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009712 · Cited by 269
Endometriosis and nuclear receptors
Yilmaz, B. D., & Bulun, S. E. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz005 · Cited by 243
Self-citationFollicular assembly: mechanisms of action
Pepling, M. E. (2011) · Reproduction · doi:10.1530/rep-11-0299 · Cited by 243
Ariazi, E. A., Brailoiu, E., Yerrum, S., Shupp, H. A., Slifker, M. J., Cunliffe, H. E., Black, M. A., Donato, A. L., Arterburn, J. B., Oprea, T. I., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3068 · Cited by 236
Estrogen Receptor Function: Impact on the Human Endometrium
Yu, K., Huang, Z., Xu, X.-L., Li, J., Fu, X., & Deng, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.827724 · Cited by 236
Autophagy in the physiological endometrium and cancer
Devis, L., Eritja, N., Davis, M. L., Matías‐Guiu, X., & Llobet‐Navàs, D. (2020) · Autophagy · doi:10.1080/15548627.2020.1752548 · Cited by 232
Steroidogenic factor-1 (SF-1, NR5A1) and human disease
Ferraz‐de‐Souza, B., Lin, L., & Achermann, J. C. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.11.006 · Cited by 191
Kuo, J., Hamid, N., Bondar, G., Prossnitz, E. R., & Micevych, P. E. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1158-10.2010 · Cited by 174
Hung, S. W., Zhang, R., Tan, Z., Chung, J. P. W., Zhang, T., & Wang, C. C. (2021) · Medicinal Research Reviews · doi:10.1002/med.21802 · Cited by 175
G Protein-Coupled Estrogen Receptor-Selective Ligands Modulate Endometrial Tumor Growth
Petrie, W. K., Dennis, M. K., Hu, C., Dai, D. D., Arterburn, J. B., Smith, H. O., Hathaway, H. J., & Prossnitz, E. R. (2013) · Obstetrics and Gynecology International · doi:10.1155/2013/472720 · Cited by 166
Yu, T., Yang, G., Hou, Y., Tang, X., Wu, C., Wu, X.-A., Guo, L., Zhu, Q., Luo, H., Du, Y.-E., et al. (2016) · Oncogene · doi:10.1038/onc.2016.370 · Cited by 150
Estrogen receptor β ligands: Recent advances and biomedical applications
Minutolo, F., Macchia, M., Katzenellenbogen, B. S., & Katzenellenbogen, J. A. (2009) · Medicinal Research Reviews · doi:10.1002/med.20186 · Cited by 151
Lebesgue, D., Traub, M., Butte-Smith, M. D., Chen, C. H., Zukin, R. S., Kelly, M. J., & Etgen, A. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008642 · Cited by 146
Ge, L.-C., Chen, Z.-J., Liu, H.-Y., Zhang, K.-S., Liu, H., Huang, H.-B., Zhang, G., Wong, C. K. C., Giesy, J. P., Du, J., et al. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.01.035 · Cited by 129
Autotaxin in the crosshairs: Taking aim at cancer and other inflammatory conditions
Benesch, M. G. K., Ko, Y. M., McMullen, T. P. W., & Brindley, D. N. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.02.009 · Cited by 129
Sandén, C., Broselid, S., Cornmark, L., Andersson, K. A., Daszkiewicz-Nilsson, J., Mårtensson, U. E. A., Olde, B., & Leeb-Lundberg, L. M. F. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.069500 · Cited by 121
Krolick, K. N., Zhu, Q., & Shi, H. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.07.008 · Cited by 126
Research advances in endometriosis-related signaling pathways: A review
Zhang, M., Xu, T., Tong, D., Li, S., Yu, X., Liu, B., Jiang, L., & Liu, K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114909 · Cited by 131
Feldman, R. D., & Limbird, L. E. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104651 · Cited by 112
Estrogen biosynthesis and signaling in endometriosis
Huhtinen, K., Ståhle, M., Perheentupa, A., & Poutanen, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.08.022 · Cited by 107
G Protein-Coupled Estrogen Receptor (GPER) Expression in Normal and Abnormal Endometrium
Plante, B. J., Lessey, B. A., Taylor, R. N., Wang, W., Bagchi, M. K., Yuan, L., Scotchie, J. G., Fritz, M. A., & Young, S. L. (2012) · Reproductive Sciences · doi:10.1177/1933719111431000 · Cited by 109
Catalano, S., Giordano, C., Panza, S., Chemi, F., Bonofiglio, D., Lanzino, M., Rizza, P., Romeo, F., Fuqua, S. A. W., Maggiolini, M., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3017-4 · Cited by 97
The signaling phospholipid PIP 3 creates a new interaction surface on the nuclear receptor SF-1
Blind, R. D., Sablin, E. P., Kuchenbecker, K. M., Chiu, H., Deacon, A. M., Das, D., Fletterick, R. J., & Ingraham, H. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416740111 · Cited by 99
Self-citationGPER-mediated proliferation and estradiol production in breast cancer-associated fibroblasts
Luo, H., Yang, G., Yu, T., Luo, S., Wu, C., Sun, Y., Liu, M., & Tu, G. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0237 · Cited by 89
Hypoxia: The force of endometriosis
Wu, M., Hsiao, K., & Tsai, S. (2019) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/jog.13900 · Cited by 88
Whitby, R. J., Stec, J., Blind, R. D., Dixon, S., Leesnitzer, L. M., Orband‐Miller, L. A., Williams, S. P., Willson, T. M., Xu, R. X., Zuercher, W. J., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1014296 · Cited by 79
Self-citationMéndez-Luna, D., Martínez‐Archundia, M., Maroun, R. C., Ceballos, G. M., Fragoso-Vázquez, M. J., González‐Juárez, D. E., & Correa‐Basurto, J. (2015) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2014.994102 · Cited by 75
Hsu, I., Yeh, C.-R., Slavin, S. A., Miyamoto, H., Netto, G. J., Tsai, Y.-C., Muyan, M., Wu, X., Messing, E. M., Guancial, E. A., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1421 · Cited by 72
Role of oestrogen receptors in bladder cancer development
Hsu, I., Vitkus, S., Da, J., & Yeh, S. (2013) · Nature Reviews Urology · doi:10.1038/nrurol.2013.53 · Cited by 71
Lee, E.-S., Sidoryk‐Wȩgrzynowicz, M., Yin, Z., Webb, A., Son, D., & Aschner, M. (2012) · Glia · doi:10.1002/glia.22329 · Cited by 70
Pupo, M., Vivacqua, A., Perrotta, I. D., Pisano, A., Aquila, S., Abonante, S., Gasperi‐Campani, A., Pezzi, V., & Maggiolini, M. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.05.023 · Cited by 72
Roy, D., Morgan, M., Yoo, C., Deoraj, A., Roy, S., Yadav, V., Garoub, M. M., Assaggaf, H. M., & Doke, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025285 · Cited by 67
The Neurosteroid Progesterone Underlies Estrogen Positive Feedback of the LH Surge
Micevych, P., & Sinchak, K. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00090 · Cited by 64
Minireview: Steroidogenic Factor 1: Its Roles in Differentiation, Development, and Disease
Schimmer, B. P., & White, P. C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.95.3.9994 · Cited by 67
The G protein-coupled estrogen receptor as a modulator of neoplastic transformation
Jacenik, D., Cygankiewicz, A. I., & Krajewska, W. M. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.04.011 · Cited by 65
Kolková, Z., Noskova, V., Ehinger, A., Hansson, S. R., & Casslén, B. G. (2010) · Molecular Human Reproduction · doi:10.1093/molehr/gaq043 · Cited by 64
Chuang, S., Chen, C., Chou, Y., Ho, M., & Chang, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186490 · Cited by 63
Activation of GPR30 inhibits cardiac fibroblast proliferation
Wang, H., Zhao, Z., Lin, M., & Groban, L. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2405-3 · Cited by 60
Low-dose Bisphenol-A regulates inflammatory cytokines through GPR30 in mammary adipose cells
Cimmino, I., Oriente, F., D’Esposito, V., Liguoro, D., Liguoro, P., Ambrosio, M. R., Cabaro, S., D’Andrea, F., Bèguinot, F., Formisano, P., et al. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0265 · Cited by 63
The effect of tamoxifen and raloxifene on estrogen metabolism and endometrial cancer risk
Williams‐Brown, M. Y., Salih, S. M., Xu, X., Veenstra, T. D., SAEED, M. K., Theiler, S., Diaz‐Arrastia, C., & Salama, S. A. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.05.001 · Cited by 59
Structure of Liver Receptor Homolog-1 (NR5A2) with PIP3 hormone bound in the ligand binding pocket
Sablin, E. P., Blind, R. D., Uthayaruban, R., Chiu, H., Deacon, A. M., Das, D., Ingraham, H. A., & Fletterick, R. J. (2015) · Journal of Structural Biology · doi:10.1016/j.jsb.2015.09.012 · Cited by 56
Self-citationPossible role of phytoestrogens in breast cancer via GPER-1/GPR30 signaling
Molina, L., Bustamante, F. A., Bhoola, K. D., Figueroa, C. D., & Ehrenfeld, P. (2018) · Clinical Science · doi:10.1042/cs20180885 · Cited by 57
Bryant, D. N., & Dorsa, D. M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.019 · Cited by 54
Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cells
Chimento, A., Casaburi, I., Bartucci, M., Patrizii, M., Dattilo, R., Avena, P., Andò, S., Pezzi, V., & Sirianni, R. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.275 · Cited by 54
Bianco, S., Brunelle, M., Jangal, M., Magnani, L., & Gévry, N. Y. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2351 · Cited by 54
G Protein-Coupled Estrogen Receptor in Energy Homeostasis and Obesity Pathogenesis
Shi, H., Kumar, S. P. D. S., & Liu, X. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-386933-3.00006-6 · Cited by 55
Oliver, K., Enewold, L., Zhu, K., Conrads, T. P., Rose, G. S., Maxwell, G. L., & Farley, J. H. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.06.027 · Cited by 53
Antiproliferation Activity of a Small Molecule Repressor of Liver Receptor Homolog 1
Corzo, C. A., Mari, Y., Chang, M. R., Khan, T. M., Kuruvilla, D. S., Nuhant, P., Kumar, N., West, G. M., Duckett, D. R., Roush, W. R., et al. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.095554 · Cited by 51
Qiao, C., Ye, W., Li, S., Wang, H., & Ding, X. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.01.014 · Cited by 50
Molecular Characterization of Membrane Steroid Receptors in Hormone-Sensitive Cancers
Masi, M., Racchi, M., Travelli, C., Corsini, E., & Buoso, E. (2021) · Cells · doi:10.3390/cells10112999 · Cited by 49
Ge, X., Guo, R., Qiao, Y., Zhang, Y., Lei, J., Wang, X., Li, L., & Hu, D. (2012) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31827912b8 · Cited by 49
Kolková, Z., Casslén, V., Hénic, E., Ahmadi, S., Ehinger, A., Jirström, K., & Casslén, B. G. (2012) · Journal of Ovarian Research · doi:10.1186/1757-2215-5-9 · Cited by 49
Li, Y., Birnbaumer, L., & Teng, C. T. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0148 · Cited by 47
IQGAP1 is a phosphoinositide effector and kinase scaffold
Choi, S., & Anderson, R. A. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.10.004 · Cited by 45
A common hypofunctional genetic variant of GPER is associated with increased blood pressure in women
Feldman, R. D., Gros, R., Ding, Q., Hussain, Y., Ban, M. R., McIntyre, A. D., & Hegele, R. A. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12471 · Cited by 46
Tamoxifen activates Nrf2-dependent SQSTM1 transcription to promote endometrial hyperplasia
Feng, L., Li, J., Yang, L., Zhu, L., Huang, X., Zhang, S., Luo, L., Jiang, Z., Jiang, T., Xu, W., et al. (2017) · Theranostics · doi:10.7150/thno.19135 · Cited by 45
Samartzis, N., Samartzis, E. P., Noske, A., Fedier, A., Dedes, K. J., Caduff, R., Fink, D., & Imesch, P. (2012) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-10-30 · Cited by 43
Liu, C., Liao, Y., Fan, S., Tang, H., Jiang, Z., Zhou, B., Xiong, J., Zhou, S., Zou, M., & Wang, J. (2015) · Medical Oncology · doi:10.1007/s12032-015-0558-2 · Cited by 43
Repression of mammary adipogenesis by genistein limits mammosphere formation of human MCF-7 cells
Montales, M. T. E., Rahal, O. M., Nakatani, H., Matsuda, T., & Simmen, R. C. M. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0520 · Cited by 43
Role of GPR30 in endometrial pathology after tamoxifen for breast cancer
Ignatov, T., Eggemann, H., Semczuk, A., Smith, B., Bischoff, J., Roessner, A., Costa, S. D., Kalinski, T., & Ignatov, A. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.07.034 · Cited by 41
Lei, B., Peng, W., Xu, G., Wu, M., Wen, Y. C., Xu, J., Yu, Z., & Wang, Y. (2016) · Chemosphere · doi:10.1016/j.chemosphere.2016.11.066 · Cited by 41
Pathological functions of hypoxia in endometriosis
Hsiao, K.-Y. (2015) · Frontiers in Bioscience · doi:10.2741/e736 · Cited by 61
Vascular effects of aldosterone: Sorting out the receptors and the ligands
Feldman, R. D., & Gros, R. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12157 · Cited by 40
Tran, Q., Firkins, R., Giles, J. R., Francis, S., Matnishian, V., Tran, P. N., VerMeer, M., Jasurda, J. S., Burgard, M., & Gebert‐Oberle, B. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.697334 · Cited by 40
Hasan, M., Marzouk, M. A., Adhikari, S., Wright, T. D., Miller, B. P., Matossian, M. D., Elliott, S. G., Wright, M. K., Alzoubi, M. S., Collins‐Burow, B. M., et al. (2019) · Molecular Pharmacology · doi:10.1124/mol.119.116202 · Cited by 40
Feldman, R. D., & Gros, R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01366.x · Cited by 39
Kenealy, B. P., Keen, K. L., Rønnekleiv, O. K., & Terasawa, E. (2011) · Endocrinology · doi:10.1210/en.2011-0097 · Cited by 39
Neuroprotective action of acute estrogens: Animal models of brain ischemia and clinical implications
Inagaki, T., & Etgen, A. M. (2013) · Steroids · doi:10.1016/j.steroids.2012.12.015 · Cited by 40
Carnesecchi, J., Malbouyres, M., Mets, R. D. M. D., Balland, M., Beauchef, G., Vié, K., Chamot, C., Lionnet, C., Ruggiero, F., & Vanacker, J.-M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120672 · Cited by 40
Feldman, R. D., Ding, Q., Hussain, Y., Limbird, L. E., Pickering, J. G., & Gros, R. (2016) · The FASEB Journal · doi:10.1096/fj.15-275552 · Cited by 38
Filigheddu, N., Sampietro, S., Chianale, F., Porporato, P. E., Gaggianesi, M., Gregnanin, I., Rainero, E., Ferrara, M., Perego, B., Riboni, F., et al. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.07.009 · Cited by 38
Phospholipid regulation of the nuclear receptor superfamily
Crowder, M. K., Seacrist, C. D., & Blind, R. D. (2016) · Advances in Biological Regulation · doi:10.1016/j.jbior.2016.10.006 · Cited by 38
Self-citationLi, Y., Chen, Y., Zhu-xia, Z., Liu, X., Yang, L., Wan, L., Lei, T., & Wang, X. (2013) · Toxicology · doi:10.1016/j.tox.2013.04.012 · Cited by 36
Chen, J., Hu, R., Ge, H., Duanmu, W., Li, Y., XUE, X., HU, S., & Feng, H. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3601 · Cited by 35
Girgert, R., Emons, G., & Gründker, C. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-935 · Cited by 34
Méndez-Luna, D., Bello, M., & Correa‐Basurto, J. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.01.001 · Cited by 35
Tian, R., Wang, Z., Shi, Z., Dong, L., Wang, Y., Zhu, Y., Lin, W., Gui, Y., & Zheng, X. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.09.011 · Cited by 33
Zhang, L., Li, Y., Lan, L., Liu, R., Wu, Y., Qu, Q., & Wen, K. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.011 · Cited by 33
He, Y., Du, G., Cai, B., Yan, Q., Zhou, L., Chen, X., Lu, W., Yang, Y.-X., & Wan, X. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1133-7 · Cited by 33
Tang, L., Li, X., Zhu, S.-Y., Wan, Y.-K., Zhang, S.-K., Ma, J., Yang, Y., Chen, A., Luo, L., & Cao, L.-Y. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.4c13961 · Cited by 34
Mori, T., Ito, F., Matsushima, H., Takaoka, O., Tanaka, Y., Koshiba, A., Kusuki, I., & Kitawaki, J. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.01.026 · Cited by 31
Signaling through non-membrane nuclear phosphoinositide binding proteins in human health and disease
Bryant, J. M., & Blind, R. D. (2018) · Journal of Lipid Research · doi:10.1194/jlr.r088518 · Cited by 27
Self-citationLiu, J., Shelkar, G. P., Zhao, F., Clausen, R. P., & Dravid, S. M. (2019) · Molecular Pharmacology · doi:10.1124/mol.119.116780 · Cited by 28
Neurosteroids, trigger of the LH surge
Kuo, J., & Micevych, P. E. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.01.008 · Cited by 27
Burnett, L. A., Light, M. M., Mehrotra, P., & Nowak, R. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2098 · Cited by 27
GPER modulators: Opportunity Nox on the heels of a class Akt
Prossnitz, E. R. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.03.005 · Cited by 26
Gros, R., Hussain, Y., Chorazyczewski, J., Pickering, J. G., Ding, Q., & Feldman, R. D. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07859 · Cited by 25
Various types of adenomyosis and endometriosis: in search of optimal management
Guo, S. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.03.021 · Cited by 24
Phosphatidylinositolphosphate phosphatase activities and cancer
Rudge, S. A., & Wakelam, M. J. O. (2015) · Journal of Lipid Research · doi:10.1194/jlr.r059154 · Cited by 25
Wang, J., Yu, R., Han, Q.-Q., Huang, H., Wang, Y.-L., Li, H., Wang, H., Chen, X., Ma, S., & Yu, J. M. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.07.017 · Cited by 24
G protein-coupled estrogen receptor 1 as a novel regulator of blood pressure
Gohar, E. Y. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00045.2020 · Cited by 24
Aiad, H. A. S., Abdelwahed, M. M., Asaad, N. Y., Tahmody, M. E., & Elhosary, E. (2014) · Apmis · doi:10.1111/apm.12241 · Cited by 22
Kampa, M., Pelekanou, V., Gallo, D., Notas, G., Troullinaki, M., Pediaditakis, I., Charalampopoulos, I., Jacquot, Y., Leclercq, G., & Castanas, E. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23309 · Cited by 22
de Valdivia, E. G., Sandén, C., Kahn, R., Olde, B., & Leeb-Lundberg, L. M. F. (2019) · Bioscience Reports · doi:10.1042/bsr20182436 · Cited by 22
Bryant, J. M., Malabanan, M. M., Vanderloop, B. H., Nichols, C. M., Haratipour, Z., Poon, K. T., Sherrod, S. D., MCLEAN, J. A. J., & Blind, R. D. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100081 · Cited by 21
Self-citation
Metadata
- Authors
- Lin, B. C., Suzawa, M., Blind, R. D., Tobias, S. C., Bulun, S. E., Scanlan, T. S., & Ingraham, H. A.
- Affiliations
- 1Pharmaceutical Chemistry and Departments of
- University of California, San Francisco (US)
- Northwestern University (US)
- Oregon Health & Science University (US)
- Venue
- Cancer Research
- Published
- 2009-07-01
- Volume
- 69
- Issue
- 13
- Pages
- 5415-5423
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC2756996
- OpenAlex
- W2103019385
- Cited by
- 157
- References
- 51
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 3 · 2023: 9 · 2022: 8 · 2021: 5 · 2020: 8 · 2019: 11 · 2018: 5 · 2017: 2 · 2016: 13 · 2015: 18 · 2014: 15 · 2013: 11 · 2012: 11
- FWCI
- 7.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- University of California, San Francisco
- National Institute of General Medical Sciences
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK063592, R01DK072246)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
- Keywords
- GPR30, G protein-coupled estrogen receptor, tamoxifen analogues, SF-1, steroidogenic factor 1, endometrial proliferation, endometriosis, endometrial cancer, PI3K signaling, MAPK signaling, phosphatidylinositol 3,4,5-trisphosphate, aromatase, genistein, estrogen signaling, choriocarcinoma
- MeSH terms
- Animals, Breast Neoplasms, Cell Division, Choriocarcinoma, Endometriosis, Estrogens, Female, Humans, Luciferases, Pregnancy, Receptors, Estrogen, Uterine Neoplasms, Endometrial Neoplasms, Genes, Reporter, Mice, Knockout, Receptors, G-Protein-Coupled, Cell Line, Tumor, Mice, Steroidogenic Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review